FreshPatents.com Logo


new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)


Similar
Filing Names

Incyte Corporation
Incyte Corporation A Delaware Corporation
Incyte Corporationn A Delaware Corporation

Popular
Companies


Web
Adobe patents
Amazon patents
Apple patents
Ebay patents
Facebook patents
Google patents
IBM patents
Linkedin patents
Microsoft patents
Oracle patents
Red Hat patents
Yahoo patents

Food/Health
Adidas
Nike patents
Pfizer patents
Monsanto patents
Medtronic patents
Kraft patents

Transportation
Boeing patents
Tesla Motors patents

Telecom
Qualcomm patents
Motorola patents
Nokia patents
RIMM patents

Industrial/Electronics
AMD
Applied Materials
Seagate patents
General Electric
Caterpillar patents
Samsung
Wal-mart patents

Ticker Symbols

Incyte Corporation patents


      
Recent patent applications related to Incyte Corporation. Incyte Corporation is listed as an Agent/Assignee. Note: Incyte Corporation may have other listings under different names/spellings. We're not affiliated with Incyte Corporation, we're just tracking patents.

ARCHIVE: New 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Incyte Corporation-related inventors



Search recent Press Releases: Incyte Corporation-related press releases
Count Application # Date Incyte Corporation patents (updated weekly) - BOOKMARK this page
12010002252201/28/10Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
22015002505601/22/15Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
32015001717301/15/15Antibodies to human transmembrane proteins
42015001154001/08/15Tricyclic heterocycles as bet protein inhibitors
52015000416501/01/15Secreted proteins
62014037729212/25/14Modulators of indoleamine 2,3-dioxygenase and methods of using the same
72014037840012/25/14Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
82014037121612/18/14Purinone derivatives as hm74a agonists
92014034303011/20/14Bipyrazole derivatives as jak inhibitors
102014031596210/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3- dioxygenase
112014027503009/18/14Tricyclic heterocycles as bet protein inhibitors
122014027503109/18/14Piperidin-4-yl azetidine derivatives as jak1 inhibitors
132014027512709/18/14Substituted heteroaryl fused derivatives as pi3k inhibitors
142014025694109/11/14Processes and intermediates for making a jak inhibitor
152014024913209/04/14Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
162014024208608/28/14Polynucleotides encoding signal peptide-containing molecules
172014024330808/28/14Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
182014024336008/28/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
192014022727508/14/14Methods of treating and diagnosing pancreatitis
202014022727808/14/14Antibodies to human signal peptide-containing proteins
212014022834608/14/14Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
222014022137908/07/14N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
232014020021607/17/14Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
242014020022707/17/14Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
252014018753007/03/14Aza spiro alkane derivatives as inhibitors of metalloproteases
262014017140506/19/14Fused pyrazoles as fgfr inhibitors
272014017140906/19/14Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
282014015528806/05/14Methods for diagnosing cancer
292014015537706/05/143-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
302014015540406/05/14Piperazinylpiperidine derivatives as chemokine receptor antagonists
312014013535005/15/14Sustained-release dosage forms of ruxolitinib
322014012119805/01/14Tricyclic fused thiophene derivatives as jak inhibitors
332014012122205/01/14Pyrimidinones as pi3k inhibitors
342014006644803/06/14Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
352014005690602/27/14Secreted proteins
362014005791202/27/14Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
372014004581402/13/14Pyrazine derivatives as fgfr inhibitors
382014003134401/30/14Azepine inhibitors of janus kinases
392014002366301/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
402014001837401/16/14Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
412014000516601/02/14Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
422014000521001/02/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
432013034515712/26/13Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
442013034522412/26/13Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
452013032451512/05/13Imidazotriazines and imidazopyrimidines as kinase inhibitors
462013025319009/26/13Processes for preparing jak inhibitors and related intermediate compounds
472013025319109/26/13Processes for preparing jak inhibitors and related intermediate compounds
482013025319309/26/13Processes for preparing jak inhibitors and related intermediate compounds
492013024378109/19/13Signal peptide-containing proteins
502013024492709/19/13Polynucleotides encoding signal peptide-containing molecules
512013024499909/19/13Substituted heterocyclic compounds
522013022476908/29/13Methods of using chemokine panec-1 antibodies
532013022555608/29/13Azetidine and cyclobutane derivatives as jak inhibitors
542013019025007/25/13Polynucleotides encoding human signal peptide-containing proteins
552013017759007/11/13N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
562013013768105/30/13Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
572013012324605/16/13Modulators of indoleamine 2,3-dioxygenase and methods of using the same
582013011623005/09/133-aminopyrrolidine derivatives as modulators of chemokine receptors
592013009614404/18/13Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors
602013005894203/07/13Human beta-adrenergic receptor kinase polypeptide and methods
612013005983503/07/13Heterocyclylamines as pi3k inhibitors
622013006002603/07/13Processes and intermediates for making a jak inhibitor
632013004596302/21/13Cyclohexyl azetidine derivatives as jak inhibitors
642013001803401/17/13Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
652013001806801/17/13Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
662012032978212/27/12Azepine inhibitors of janus kinases
672012030146411/29/12Janus kinase inhibitors for treatment of dry eye and other eye related diseases
682012029591211/22/12Piperazinylpiperidine derivatives as chemokine receptor antagonists
692012027080910/25/12Human transmembrane proteins
702012012285805/17/12Lactam compounds and their use as pharmaceuticals
712012004096402/16/12N-substituted piperidines and their use as pharmaceuticals
722012003517202/09/12Purinone derivatives as hm74a agonists
732012001493701/19/12Human beta-adrenergic receptor kinase polypeptide and methods
742012001592801/19/12Amido compounds and their use as pharmaceuticals
752011025121510/13/11Macrocyclic compounds and their use as kinase inhibitors
762011021296709/01/11Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
772011020775408/25/11Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
782011013678106/09/11Imidazotriazines and imidazopyrimidines as kinase inhibitors
792011008681004/14/11Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d] pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
802011008215904/07/11Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
812011005321703/03/11Polynucleotides encoding signal peptide-containing molecules
822010027933311/04/10Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid
832010025611410/07/10Amido compounds and their use as pharmaceuticals
842010024067109/23/10Substituted heterocyclic compounds
852010020303908/12/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
862010019080407/29/10Macrocyclic compounds and their use as kinase inhibitors
872010017390107/08/10Substituted heterocyclic compounds
882010013740106/03/102-methylprop anamides and their use as pharmaceuticals
892010011950305/13/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
902010009961704/22/10Secreted proteins
912009031840512/24/094-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
922009029194611/26/09Lactam compounds and their use as pharmaceuticals
932009028677411/19/09Purinone derivatives as hm74a agonists
942009028677811/19/09Macrocyclic compounds and their use as kinase inhibitors
952009027468011/05/09Human phospholipases
962009023390309/17/09Azetidine and cyclobutane derivatives as jak inhibitors
972009021576608/27/09Tetracyclic inhibitors of janus kinases
982009019788708/06/09Piperazinylpiperidine derivatives as chemokine receptor antagonists
992009018195907/16/09Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1002009012464905/14/09Aza spiro alkane derivatives as inhibitors of metalloproteases
1012009008844604/02/09Purinone derivatives as hm74a agonists
1022009007626903/19/09Purinone derivatives as hm74a agonists
1032012026367610/18/12Compositions, methods and kits relating to her-2 cleavage
1042012005807903/08/121,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
1052012001498901/19/12Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
1062011031147912/22/11Modulators of indoleamine 2,3-dioxygenase and methods of using the same
1072011022321009/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1082011022415709/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1092011017227907/14/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1102011016518807/07/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1112011008683504/14/11Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
1122009029880812/03/09Inhibitors of 11-beta hydroxyl steroid dehydrogenase type i and methods of using the same
1132009019786908/06/09Azepine inhibitors of janus kinases


ARCHIVE: New 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Incyte Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Incyte Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###

     SHARE